Elimination of CD4+ suppressor T cells from susceptible BALB/c mice releases CD8+ T lymphocytes to mediate protective immunity against Leishmania
about
Recombinant vaccinia viruses expressing GP46/M-2 protect against Leishmania infectionGamma interferon response in secondary Leishmania major infection: role of CD8+ T cellsAn avirulent lipophosphoglycan-deficient Leishmania major clone induces CD4+ T cells which protect susceptible BALB/c mice against infection with virulent L. majorExperimental Validation of Multi-Epitope Peptides Including Promising MHC Class I- and II-Restricted Epitopes of Four Known Leishmania infantum Proteins.Differences in gamma interferon production in vitro predict the pace of the in vivo response to Leishmania amazonensis in healthy volunteers.Perforin and gamma interferon are critical CD8+ T-cell-mediated responses in vaccine-induced immunity against Leishmania amazonensis infection.Leishmania-reactive CD4+ and CD8+ T cells associated with cure of human cutaneous leishmaniasis.CD8(+) T cells in leishmania infections: friends or foes?Intrapulmonary growth and dissemination of an avirulent strain of Cryptococcus neoformans in mice depleted of CD4+ or CD8+ T cellsThe interaction between CD8+ cytotoxic T cells and Leishmania-infected macrophagesCure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism.The dual nature of specific immunological activity of tumor-derived gp96 preparations.T helper subset differentiation in the absence of invariant chainVaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania majorLeishmaniases of the New World: current concepts and implications for future researchImmunomodulation of mouse macrophage killing of Mycobacterium avium in vitroAdoptive transfer of skin-selective autoimmunity induced by Skn alloantigenic disparitiesProduction of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis.Role of cytokines and CD4+ T-cell subsets in the regulation of parasite immunity and disease.Contact sensitization induces proliferation of heterogeneous populations of hapten-specific T cells.Analysis of the cellular parameters of the immune responses contributing to resistance and susceptibility of mice to infection with the intracellular parasite, Leishmania major.Effective and long-lasting immunity against the parasite Leishmania major in CD8-deficient mice.The kinetoplastid membrane protein 11 of Leishmania donovani and African trypanosomes is a potent stimulator of T-lymphocyte proliferation.Leishmania phagolysosome: drug trafficking and protein sorting across the compartment.Cytotoxic activity in cutaneous leishmaniasis.Immunologic patterns associated with cure in human American cutaneous leishmaniasis.Immunomodulation of Chiclero's ulcer. Role of eosinophils, T cells, tumour necrosis factor and interleukin-2.Vaccination with Trichinella spirallis antigens increases CD8+ peripheral T cells and enhances the Th2 immune response in Leishmania infantum challenged mice.
P2860
Q33604990-FF84970D-FF64-438B-A381-F72D802521BAQ33607724-EC7093F1-CA60-413A-8318-1B188C43C91BQ33617127-5F3F2DD2-6E1D-4D49-BAD5-DEE3D95FB09CQ33732102-26A6FF0F-F8A5-4FEF-95E9-382576AECFBFQ34009680-59376B85-C25E-44A3-89C5-8F1A709FDB2AQ35011520-A4FE6316-3F2F-4ABD-94B4-C9BBBC89687BQ35783219-96843FF3-C42F-40EA-B03D-610BF0EEBDA6Q35927465-E8416629-BC53-4CDD-9F1F-B0DDE675BCC7Q36229937-2A0D215A-72AD-4A9A-B339-74BFA5BAA509Q36230374-7B2AF74F-A6C8-43F1-9F03-3D83CD44F4CDQ36350176-02CC8BE5-159E-4084-B4B8-98C328EEBA0AQ36368193-2ED9653E-3BAC-4CEA-97A2-8AD05C509E4CQ36376680-3D6562F8-416E-489E-950C-CE7F180E51F5Q36380692-CCEFE80D-DA88-4769-A64D-5A600775918CQ36640255-615BBFE2-4B72-4895-95C3-40E3EC0990ECQ36961332-A92E11E5-21B0-431F-A84A-5AE8A767783AQ37306402-49805DB6-DE2F-4C0C-9BF3-B7EC8C40C5A7Q37574082-8CACCA00-EB75-46E1-92A8-7F4B0EFE969FQ38370347-1D2B8839-9F18-4BED-97BB-D4663391A82CQ38510523-374AAA2A-F3C2-4F00-88CF-BD823E2439BFQ38749527-D6A6AA39-BE9E-4426-8421-2A0FE0B29B69Q39572606-C37985BC-24CF-4113-8665-01130F73E1FEQ40376054-C98BBFCB-50DE-47FA-87A9-4D60AED86DC2Q41623601-C58F1B21-20EA-4B6A-AF12-76C66F13F58DQ46270906-82B40E58-CBBF-4303-8C25-85B858C72374Q47758388-975DEBBE-4D26-48A2-828D-7F6AFFCC2C7BQ47972739-8764F880-09E2-4D7B-B95A-39446933201BQ51753182-DF7723B4-1A39-4081-8DAD-C193E92C28E2
P2860
Elimination of CD4+ suppressor T cells from susceptible BALB/c mice releases CD8+ T lymphocytes to mediate protective immunity against Leishmania
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
Elimination of CD4+ suppressor ...... ve immunity against Leishmania
@ast
Elimination of CD4+ suppressor ...... ve immunity against Leishmania
@en
type
label
Elimination of CD4+ suppressor ...... ve immunity against Leishmania
@ast
Elimination of CD4+ suppressor ...... ve immunity against Leishmania
@en
prefLabel
Elimination of CD4+ suppressor ...... ve immunity against Leishmania
@ast
Elimination of CD4+ suppressor ...... ve immunity against Leishmania
@en
P2093
P2860
P356
P1476
Elimination of CD4+ suppressor ...... ve immunity against Leishmania
@en
P2093
P2860
P304
P356
10.1084/JEM.169.5.1819
P407
P577
1989-05-01T00:00:00Z